MARKET

CHMMF

CHMMF

Chimeric Therap
OTCPK
0.0010
NaN%
Closed 09:30 12/26 EST
OPEN
--
PREV CLOSE
0.0010
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0010
52 WEEK LOW
0.0010
MARKET CAP
3.64M
P/E (TTM)
-0.2083
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CHMMF last week (0908-0912)?
Weekly Report · 09/15 10:33
Weekly Report: what happened at CHMMF last week (0901-0905)?
Weekly Report · 09/08 10:35
Weekly Report: what happened at CHMMF last week (0825-0829)?
Weekly Report · 09/01 10:32
Weekly Report: what happened at CHMMF last week (0818-0822)?
Weekly Report · 08/25 10:39
Weekly Report: what happened at CHMMF last week (0811-0815)?
Weekly Report · 08/18 10:34
Weekly Report: what happened at CHMMF last week (0804-0808)?
Weekly Report · 08/11 10:39
Weekly Report: what happened at CHMMF last week (0728-0801)?
Weekly Report · 08/04 10:41
Weekly Report: what happened at CHMMF last week (0721-0725)?
Weekly Report · 07/28 10:42
More
About CHMMF
Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.

Webull offers Chimeric Therapeutics Ltd stock information, including OTCPK: CHMMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHMMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHMMF stock methods without spending real money on the virtual paper trading platform.